CRISPR-Cas gene editing technology and its application prospect in medicinal plants

被引:13
|
作者
Guo, Miaoxian [1 ]
Chen, Hongyu [1 ]
Dong, Shuting [1 ]
Zhang, Zheng [1 ]
Luo, Hongmei [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Plant Dev, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
CRISPR-Cas; Gene editing; Reverse genetics; Synthetic biology; Genetic improvement; Medicinal plants; DENDROBIUM-OFFICINALE; TARGETED MUTAGENESIS; SALVIA-MILTIORRHIZA; CRYSTAL-STRUCTURE; DNA CLEAVAGE; GENOMIC DNA; GUIDE-RNA; EVOLUTION; DIVERSITY; SYSTEMS;
D O I
10.1186/s13020-022-00584-w
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas gene editing technology has opened a new era of genome interrogation and genome engineering because of its ease operation and high efficiency. An increasing number of plant species have been subjected to site-directed gene editing through this technology. However, the application of CRISPR-Cas technology to medicinal plants is still in the early stages. Here, we review the research history, structural characteristics, working mechanism and the latest derivatives of CRISPR-Cas technology, and discussed their application in medicinal plants for the first time. Furthermore, we creatively put forward the development direction of CRISPR technology applied to medicinal plant gene editing. The aim is to provide a reference for the application of this technology to genome functional studies, synthetic biology, genetic improvement, and germplasm innovation of medicinal plants. CRISPR-Cas is expected to revolutionize medicinal plant biotechnology in the near future.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] CRISPR-Cas gene editing technology and its application prospect in medicinal plants
    Miaoxian Guo
    Hongyu Chen
    Shuting Dong
    Zheng Zhang
    Hongmei Luo
    [J]. Chinese Medicine, 17
  • [2] The emerging patent landscape of CRISPR-Cas gene editing technology
    Egelie, Knut J.
    Graff, Gregory D.
    Strand, Sabina P.
    Johansen, Berit
    [J]. NATURE BIOTECHNOLOGY, 2016, 34 (10) : 1025 - 1032
  • [3] Enhancement of specialized metabolites using CRISPR/Cas gene editing technology in medicinal plants
    Das, Swati
    Kwon, Moonhyuk
    Kim, Jae-Yean
    [J]. FRONTIERS IN PLANT SCIENCE, 2024, 15
  • [4] CRISPR-Cas Gene Editing to the Genetic Rescue
    Goetzl, Edward J.
    Alpert, Joseph S.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2024, 137 (05): : 386 - 389
  • [5] The CRISPR-Cas toolbox and gene editing technologies
    Liu, Guanwen
    Lin, Qiupeng
    Jin, Shuai
    Gao, Caixia
    [J]. MOLECULAR CELL, 2022, 82 (02) : 333 - 347
  • [6] Editing plants for virus resistance using CRISPR-Cas
    Green, J. C.
    Hu, J. S.
    [J]. ACTA VIROLOGICA, 2017, 61 (02) : 138 - 142
  • [7] FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology
    Grant, Evita V.
    [J]. FOOD AND DRUG LAW JOURNAL, 2016, 71 (04) : 608 - 633
  • [8] Transient CRISPR-Cas Delivery for Therapeutic Gene Editing in the Retina
    Botto, Catherine
    Pulman, Juliette
    Eriksson, Hanna
    Fradot, Valerie
    De Cian, Anne
    Concordet, Jean-Paul
    El-Amraoui, Aziz
    Dalkara, Deniz
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 149 - 149
  • [9] Harnessing CRISPR-Cas system diversity for gene editing technologies
    Alexander McKay
    Gaetan Burgio
    [J]. The Journal of Biomedical Research, 2021, 35 (02) : 91 - 106
  • [10] Editing of the urease gene by CRISPR-Cas in the diatom Thalassiosira pseudonana
    Amanda Hopes
    Vladimir Nekrasov
    Sophien Kamoun
    Thomas Mock
    [J]. Plant Methods, 12